Search

Your search keyword '"Lee, Richard W. J."' showing total 156 results

Search Constraints

Start Over You searched for: Author "Lee, Richard W. J." Remove constraint Author: "Lee, Richard W. J." Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
156 results on '"Lee, Richard W. J."'

Search Results

1. Author Correction: Identification of an intraocular microbiota

3. Identification of an intraocular microbiota

6. Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial

7. Systemic immunosuppression depletes peripheral blood regulatory B cells in patients with immune thrombocytopenia.

10. Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial

11. Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A

12. Steroid Sensitivity in Uveitis

18. Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration

19. Glucocorticoid treatment in patients with newly diagnosed immune thrombocytopenia switches CD14 ++ CD16 + intermediate monocytes from a pro‐inflammatory to an anti‐inflammatory phenotype

21. Intravenous indocyanine green dye is insufficient for robust immune cell labelling in the human retina

24. CD4+ T cells from patients with glucocorticoid‐refractory immune thrombocytopenia have altered cytokine expression.

25. Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood–Retinal Barrier Integrity In Vitro

27. The DNA Methylation Inhibitor Zebularine Controls CD4+ T Cell Mediated Intraocular Inflammation

29. Glucocorticoid treatment in patients with newly diagnosed immune thrombocytopenia switches CD14++CD16+ intermediate monocytes from a pro‐inflammatory to an anti‐inflammatory phenotype.

34. Human Th17 cells produce a soluble mediator that increases podocyte motility via signaling pathways that mimic PAR-1 activation.

35. The DNA Methylation Inhibitor Zebularine Controls CD4+ T Cell Mediated Intraocular Inflammation.

37. CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses

38. RETINAL VESSEL CALIBER CHANGES IN VASCULITIS

41. The Bromodomain and Extra-Terminal Protein Inhibitor OTX015 Suppresses T Helper Cell Proliferation and Differentiation

44. Phase IIb clinical trial of ranibizumab for the treatment of uveitic and idiopathic choroidal neovascular membranes.

Catalog

Books, media, physical & digital resources